Simultaneous monitoring of fibrinogen and haematocrit in whole blood

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9909977
SERIAL NO

15029266

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for determining both (a) the haematocrit value and (b) the fibrinogen content in whole blood of an individual in less than 5 minutes, as well as to associated portable apparatus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS55 BOULEVARD DIDEROT PARIS 75012
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE PARIS DESCARTESPARIS FRA PARIS PARIS
ETAT FRANCAIS (MINISTERE DE LA DEFENSE) SERVICE DE SANTE DES ARMEES75614 PARIS CEDEX 12

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gaussem, Pascale Paris, FR 3 0
Godier, Anne Paris, FR 1 0
Gouin-Thibault, Isabelle Paris, FR 1 0
Le, Bonniec Bernard Paris, FR 3 25
Martin, Anne-Celine Paris, FR 2 0
Morravedge, Nyoucha Paris, FR 1 0
Samama, Marc Paris, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00